Anticuerpos monoclonales en COVID 19: Casirivimab+Imdevimab.
| dc.contributor.author | Instituto Global para la Excelencia en el Cuidado de la Salud Keralty | |
| dc.date.accessioned | 2026-04-10T15:42:31Z | |
| dc.date.available | 2026-04-10T15:42:31Z | |
| dc.date.issued | 2021 | |
| dc.format | text | |
| dc.identifier.uri | https://repositorio.unisanitas.edu.co/handle/123456789/1181 | |
| dc.language.iso | es | |
| dc.publisher | Keralty | |
| dc.title | Anticuerpos monoclonales en COVID 19: Casirivimab+Imdevimab. | |
| dc.type | Documento |